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Objectives: 
To study the clinical profile, relative proportions and outcome with treatment of patients with 
Peripheral T cell lymphomas (PTCLs) and to identify the parameters that can predict 
prognosis in PTCLs. 
Patients and methods:  
This is a retrospective analysis of patients with PTCL from January 2007 to December 2012. 
All patients with age 18 years and above were included in this study. Patients with cutaneous 
T cell lymphomas were excluded. Results were analyzed in terms of the clinical 
characteristics and laboratory parameters at diagnosis, response to the different treatment 
regimens, the survival patterns and the prognostic effects of patient characteristics on overall 
survival. Survival curves were drawn by the Kaplan-Meier method and compared by the log-
rank test. A 2-sided P-value of 0.05 or less was considered statistically significant.  
Results: 
There were a total of 243 adult patients (age ≥18 years) diagnosed to have PTCL. Most 
common histological subtype was found to be PTCL-not otherwise specified (NOS) (35.8%) 
followed by ALK negative Anaplastic large cell lymphoma (ALCL) (21.4%). For NK/T cell 
lymphoma, risk categorisation by NK/T cell lymphoma Prognostic Index (NKPI) was better 
compared to International Prognostic Index (IPI). The 5 year overall survival and event free 
survival for patients who received chemotherapy (n=121) was 30.4% ± 5.5% and 28.5% ± 
4.7% respectively. Best outcome was seen in patients with ALK positive ALCL and worst for 
Hepatosplenic T cell lymphoma.  
Conclusions: 
Outcome of PTCLs (except ALK positive ALCL) was poor compared to B cell lymphomas 
with the use of CHOP based chemotherapy. NKPI is a better prognostic score for NK/T cell 
lymphoma compared to IPI. 
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